P2RX7 blocker (Axxam SpA)

N/A

Report date: 2025/01/26 16:39:45
NME

Base Information

Drug NameP2RX7 blocker (Axxam SpA)
Drug Alias NameP2X7 blocker (Axxam)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 7 antagonists
TargetsP2X purinoceptor 7
Therapy Area/IndicationsPainNerve DegenerationAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAxxam Spa
China Registration ClassN/A

Develop Information

Active CompaniesBreye Therapeutics ApS
Inactive CompaniesAxxam SpaGolgi Neurosciences SRL
Active IndicationsGeographic Atrophy
Inactive IndicationsPainNerve DegenerationAutoimmune Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A